Preliminary results of a short-course antituberculosis regimen including Sinerdol-EH and applied under operational conditions.
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D012293:Rifampin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
C039205:Sinerdol EH; D012293:Rifampin